bf/NYSE:GKOS_icon.jpeg

NYSE:GKOS

Glaukos

  • Stock

USD

Last Close

81.79

06/11 21:10

Market Cap

6.05B

Beta: 1.24

Volume Today

4.56M

Avg: 391.41K

PE Ratio

−34.36

PFCF: −69.66

    Description

    Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. ...Show More

    Earnings

    Earnings per Share (Estimate*)

    -1-0.50.512018-12-312020-08-062021-12-312023-11-012024-11-04

    Revenue (Estimate*)

    50M100M150M200M250M300M350M2018-12-312020-08-062021-12-312023-11-012024-11-04

    *Estimate based on analyst consensus